Novartis Ag (NVSEF) EBIT Margin Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) EBIT Margin Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 1,388.00
Jun 30, 2024 944.00
Dec 31, 2023 -7,955.00
Jun 30, 2023 566.00
Mar 31, 2023 -9,447.00
Dec 31, 2022 -4,351.00
Sep 30, 2022 -4,338.00
Jun 30, 2022 -119.00
Dec 31, 2021 -1,412.00
Sep 30, 2021 539.00
Jun 30, 2021 -21,214.00
Mar 31, 2021 -7,204.00
Dec 31, 2020 -17,859.00
Sep 30, 2020 -10,162.00
Jun 30, 2020 -15,490.00
Mar 31, 2020 -24,550.00
Jun 30, 2019 -47,315.00
Mar 31, 2019 -69,588.00
Dec 31, 2018 6,181.00
Jun 30, 2018 -7,772.00